FDA NDA 209988, FUROSCIX, SCPHARMACEUTICALS, 10/07/2022

Contents: Summary Basis of Approval (Approval Package) for NDA 209988 [Furoscix (furosemide injection)] approved on October 7, 2022.

NDA: 209988
Company: SCPHARMACEUTICALS
Drug Name: FUROSCIX
Active Ingredients: FUROSEMIDE
Strength: 80MG/10ML (8MG/ML)
Dosage Form/Route: SOLUTION;SUBCUTANEOUS
Action Date: 10/07/2022
Marketing Status: Prescription
Submission Classification: ORIG-1
Action Date: None

658 Pages

PUBLICLY AVAILABLE (we charge a convenience fee for download)